首页 > 最新文献

Current Protocols in Cytometry最新文献

英文 中文
Flow Cytometry Instrumentation – An Overview 流式细胞仪仪器-概述
Q1 Health Professions Pub Date : 2018-11-16 DOI: 10.1002/cpcy.52
Martin Büscher

The term flow cytometry, used since the seventies, describes a technology employed mainly in biology and medicine to measure and classify suspended particles, e.g., cells or microspheres. Measurable cell parameters include: geometric properties, such as cell size (diameter, surface area, volume); physiological properties (membrane potential, integrity, vitality); and quantities of DNA, RNA, cytokines, surface antigens, nuclear antigens, enzymes, and proteins. © 2018 by John Wiley & Sons, Inc.

流式细胞术这个术语自70年代开始使用,描述了一种主要用于生物学和医学的技术,用于测量和分类悬浮颗粒,例如细胞或微球。可测量的电池参数包括:几何特性,如电池尺寸(直径、表面积、体积);生理特性(膜电位、完整性、活力);以及DNA、RNA、细胞因子、表面抗原、核抗原、酶和蛋白质的数量。©2018 by John Wiley &儿子,Inc。
{"title":"Flow Cytometry Instrumentation – An Overview","authors":"Martin Büscher","doi":"10.1002/cpcy.52","DOIUrl":"10.1002/cpcy.52","url":null,"abstract":"<p>The term flow cytometry, used since the seventies, describes a technology employed mainly in biology and medicine to measure and classify suspended particles, e.g., cells or microspheres. Measurable cell parameters include: geometric properties, such as cell size (diameter, surface area, volume); physiological properties (membrane potential, integrity, vitality); and quantities of DNA, RNA, cytokines, surface antigens, nuclear antigens, enzymes, and proteins. © 2018 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"87 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.52","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36675749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Flow Cytometry Method Validation Protocols 流式细胞术方法验证方案
Q1 Health Professions Pub Date : 2018-11-12 DOI: 10.1002/cpcy.53
Nithianandan Selliah, Steven Eck, Cherie Green, Teri Oldaker, Jennifer Stewart, Alessandra Vitaliti, Virginia Litwin

Analytical method validation provides a means to ensure that data are credible and reproducible. This unit will provide a brief introduction to analytical method validation as applied to cellular analysis by flow cytometry. In addition, the unit will provide practical procedures for three different types of validation. The first is a limited validation protocol that is applicable for research settings and non-regulated laboratories. The second is validation protocol that presents the minimum validation requirements in regulated laboratories. The third is a transfer validation protocol to be used when methods are transferred between laboratories. The recommendations presented in this unit are consistent with the white papers published by the American Association of Pharmaceutical Scientists and the International Clinical Cytometry Society, as well as with Clinical Laboratory Standards Institute Guideline H62: Validation of Assays Performed by Flow Cytometry (currently in preparation). © 2018 by John Wiley & Sons, Inc.

分析方法验证提供了一种确保数据可信和可重复的手段。本单元将简要介绍流式细胞术应用于细胞分析的分析方法验证。此外,该单元将为三种不同类型的验证提供实用程序。第一个是适用于研究环境和非管制实验室的有限验证方案。第二个是验证方案,它提出了在受监管的实验室中最低的验证要求。第三是在实验室之间转移方法时使用的转移验证协议。本单元中提出的建议与美国药物科学家协会和国际临床细胞术学会发表的白皮书以及临床实验室标准协会指南H62:流式细胞术检测的验证(目前正在准备中)一致。©2018 by John Wiley &儿子,Inc。
{"title":"Flow Cytometry Method Validation Protocols","authors":"Nithianandan Selliah,&nbsp;Steven Eck,&nbsp;Cherie Green,&nbsp;Teri Oldaker,&nbsp;Jennifer Stewart,&nbsp;Alessandra Vitaliti,&nbsp;Virginia Litwin","doi":"10.1002/cpcy.53","DOIUrl":"10.1002/cpcy.53","url":null,"abstract":"<p>Analytical method validation provides a means to ensure that data are credible and reproducible. This unit will provide a brief introduction to analytical method validation as applied to cellular analysis by flow cytometry. In addition, the unit will provide practical procedures for three different types of validation. The first is a limited validation protocol that is applicable for research settings and non-regulated laboratories. The second is validation protocol that presents the minimum validation requirements in regulated laboratories. The third is a transfer validation protocol to be used when methods are transferred between laboratories. The recommendations presented in this unit are consistent with the white papers published by the American Association of Pharmaceutical Scientists and the International Clinical Cytometry Society, as well as with Clinical Laboratory Standards Institute Guideline H62: Validation of Assays Performed by Flow Cytometry (currently in preparation). © 2018 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"87 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.53","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36656832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiphoton Imaging of Collagen, Elastin, and Calcification in Intact Soft-Tissue Samples 完整软组织标本中胶原蛋白、弹性蛋白和钙化的多光子成像
Q1 Health Professions Pub Date : 2018-10-31 DOI: 10.1002/cpcy.51
Piyusha S. Gade, Anne M. Robertson, Chih-Yuan Chuang

Multiphoton-induced second-harmonic generation and two-photon excitation enable imaging of collagen and elastin fibers at micron-level resolution to depths of hundreds of microns, without the use of exogenous stains. These attributes can be leveraged for quantitative analysis of the 3D architecture of collagen and elastin fibers within intact, soft tissue specimens such as the artery and bladder wall. This architecture influences the function of intramural cells and also plays a primary role in determining tissue passive mechanical properties. Calcification deposition in soft tissues is a highly prevalent pathology in both older and diseased populations that can alter tissue properties. In this unit, we provide a protocol for simultaneous multiphoton microscopy (MPM) imaging and analysis of 3D collagen and elastin structures with calcification, which is effective for fixed and fresh intact samples. We also provide an associated micro-CT protocol to identify regions of interest in the samples as a means to target the MPM imaging. © 2018 by John Wiley & Sons, Inc.

多光子诱导的二次谐波产生和双光子激发使胶原蛋白和弹性蛋白纤维在微米级分辨率下成像到数百微米深度,而无需使用外源染色剂。这些属性可以用于对完整软组织标本(如动脉和膀胱壁)内胶原蛋白和弹性蛋白纤维的3D结构进行定量分析。这种结构影响着壁内细胞的功能,也在决定组织被动力学性能方面起着主要作用。软组织钙化沉积在老年人和患病人群中都是一种非常普遍的病理,可以改变组织特性。在本单元中,我们提供了一种同时多光子显微镜(MPM)成像和分析具有钙化的三维胶原和弹性蛋白结构的方案,该方案适用于固定和新鲜完整的样品。我们还提供了一种相关的微ct方案,以确定样品中感兴趣的区域,作为靶MPM成像的手段。©2018 by John Wiley &儿子,Inc。
{"title":"Multiphoton Imaging of Collagen, Elastin, and Calcification in Intact Soft-Tissue Samples","authors":"Piyusha S. Gade,&nbsp;Anne M. Robertson,&nbsp;Chih-Yuan Chuang","doi":"10.1002/cpcy.51","DOIUrl":"10.1002/cpcy.51","url":null,"abstract":"<p>Multiphoton-induced second-harmonic generation and two-photon excitation enable imaging of collagen and elastin fibers at micron-level resolution to depths of hundreds of microns, without the use of exogenous stains. These attributes can be leveraged for quantitative analysis of the 3D architecture of collagen and elastin fibers within intact, soft tissue specimens such as the artery and bladder wall. This architecture influences the function of intramural cells and also plays a primary role in determining tissue passive mechanical properties. Calcification deposition in soft tissues is a highly prevalent pathology in both older and diseased populations that can alter tissue properties. In this unit, we provide a protocol for simultaneous multiphoton microscopy (MPM) imaging and analysis of 3D collagen and elastin structures with calcification, which is effective for fixed and fresh intact samples. We also provide an associated micro-CT protocol to identify regions of interest in the samples as a means to target the MPM imaging. © 2018 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"87 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.51","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10264826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Cell Cycle Analysis of Hematopoietic Stem and Progenitor Cells by Multicolor Flow Cytometry 多色流式细胞术分析造血干细胞和祖细胞的细胞周期
Q1 Health Professions Pub Date : 2018-10-18 DOI: 10.1002/cpcy.50
Amy Galvin, Meredith Weglarz, Kat Folz-Donahue, Maris Handley, Misa Baum, Michael Mazzola, Hannah Litwa, David T. Scadden, Lev Silberstein

Maintenance of hematopoietic stem cell (HSC) quiescence is critical for self-renewal and differentiation into mature lineages. Therefore, the ability to reliably detect abnormal HSC cycling is essential for experiments that seek to investigate abnormalities of HSC function. The ability to reproducibly evaluate cell cycle status in a rare cell subset requires careful optimization of multiple parameters during cell preparation and sample processing. Here, we describe a method where data acquisition parameters and fluorochrome combination for long-term HSC staining have been specifically designed for concurrent use with DAPI and Ki-67 antibodies. © 2018 by John Wiley & Sons, Inc.

维持造血干细胞(HSC)的静止是自我更新和分化为成熟谱系的关键。因此,可靠地检测异常造血干细胞循环的能力对于研究造血干细胞功能异常的实验至关重要。在罕见的细胞子集中可重复地评估细胞周期状态的能力需要在细胞制备和样品处理过程中仔细优化多个参数。在这里,我们描述了一种方法,其中数据采集参数和用于长期HSC染色的荧光染料组合是专门为DAPI和Ki-67抗体同时使用而设计的。©2018 by John Wiley &儿子,Inc。
{"title":"Cell Cycle Analysis of Hematopoietic Stem and Progenitor Cells by Multicolor Flow Cytometry","authors":"Amy Galvin,&nbsp;Meredith Weglarz,&nbsp;Kat Folz-Donahue,&nbsp;Maris Handley,&nbsp;Misa Baum,&nbsp;Michael Mazzola,&nbsp;Hannah Litwa,&nbsp;David T. Scadden,&nbsp;Lev Silberstein","doi":"10.1002/cpcy.50","DOIUrl":"10.1002/cpcy.50","url":null,"abstract":"<p>Maintenance of hematopoietic stem cell (HSC) quiescence is critical for self-renewal and differentiation into mature lineages. Therefore, the ability to reliably detect abnormal HSC cycling is essential for experiments that seek to investigate abnormalities of HSC function. The ability to reproducibly evaluate cell cycle status in a rare cell subset requires careful optimization of multiple parameters during cell preparation and sample processing. Here, we describe a method where data acquisition parameters and fluorochrome combination for long-term HSC staining have been specifically designed for concurrent use with DAPI and Ki-67 antibodies. © 2018 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"87 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.50","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36639032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Issue Information TOC 发布信息TOC
Q1 Health Professions Pub Date : 2018-10-01 DOI: 10.1002/cpcy.45
{"title":"Issue Information TOC","authors":"","doi":"10.1002/cpcy.45","DOIUrl":"10.1002/cpcy.45","url":null,"abstract":"","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"86 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.45","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47961223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flow Cytometric Monitoring for Residual Disease in B Lymphoblastic Leukemia Post T Cell Engaging Targeted Therapies T细胞靶向治疗后B淋巴细胞白血病残留病变的流式细胞术监测
Q1 Health Professions Pub Date : 2018-09-13 DOI: 10.1002/cpcy.44
Sindhu Cherian, Maryalice Stetler-Stevenson

The use of targeted therapy is growing in the setting of hematopoietic neoplasms. Flow cytometry is a cornerstone of residual disease monitoring post therapy in this group of malignancies. Often, there is overlap between antigens targeted by immunotherapies and gating reagents utilized for population identification by flow cytometry. Such overlap can render a previously excellent gating reagent inadequate for disease detection. Recently, several anti–CD19 T cell–engaging immunotherapeutic agents and an anti-CD22 immunotoxin have been FDA approved for use in B lymphoblastic leukemia (B-LL), with an anti–CD22 T cell–engaging agent in development. In the setting of such targeted therapies, CD19 and CD22 expression may be altered, compromising the use of these reagents for identification of abnormal blasts. We describe herein a strategy for flow cytometric monitoring for residual disease in patients with B-LL post T cell–engaging anti-CD19 and anti-CD22 therapies. © 2018 by John Wiley & Sons, Inc.

靶向治疗在造血肿瘤治疗中的应用越来越广泛。流式细胞术是这组恶性肿瘤治疗后残留疾病监测的基石。通常,免疫疗法靶向的抗原和流式细胞术用于群体鉴定的门控试剂之间存在重叠。这种重叠会使以前优良的门控试剂不适用于疾病检测。最近,几种抗cd19 T细胞免疫治疗药物和一种抗cd22免疫毒素已被FDA批准用于B淋巴细胞白血病(B- ll),一种抗cd22 T细胞免疫治疗药物正在开发中。在这种靶向治疗的情况下,CD19和CD22的表达可能会改变,从而影响这些试剂用于鉴定异常细胞的使用。我们在此描述了一种流式细胞术监测B-LL后T细胞参与抗cd19和抗cd22治疗的患者残留疾病的策略。©2018 by John Wiley &儿子,Inc。
{"title":"Flow Cytometric Monitoring for Residual Disease in B Lymphoblastic Leukemia Post T Cell Engaging Targeted Therapies","authors":"Sindhu Cherian,&nbsp;Maryalice Stetler-Stevenson","doi":"10.1002/cpcy.44","DOIUrl":"10.1002/cpcy.44","url":null,"abstract":"<p>The use of targeted therapy is growing in the setting of hematopoietic neoplasms. Flow cytometry is a cornerstone of residual disease monitoring post therapy in this group of malignancies. Often, there is overlap between antigens targeted by immunotherapies and gating reagents utilized for population identification by flow cytometry. Such overlap can render a previously excellent gating reagent inadequate for disease detection. Recently, several anti–CD19 T cell–engaging immunotherapeutic agents and an anti-CD22 immunotoxin have been FDA approved for use in B lymphoblastic leukemia (B-LL), with an anti–CD22 T cell–engaging agent in development. In the setting of such targeted therapies, CD19 and CD22 expression may be altered, compromising the use of these reagents for identification of abnormal blasts. We describe herein a strategy for flow cytometric monitoring for residual disease in patients with B-LL post T cell–engaging anti-CD19 and anti-CD22 therapies. © 2018 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"86 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.44","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36489826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Deriving Extracellular Vesicle Size From Scatter Intensities Measured by Flow Cytometry 从流式细胞术测量的散射强度中得出细胞外囊泡大小
Q1 Health Professions Pub Date : 2018-08-31 DOI: 10.1002/cpcy.43
Leonie de Rond, Frank A. W. Coumans, Rienk Nieuwland, Ton G. van Leeuwen, Edwin van der Pol

Flow cytometry is commonly used to investigate the potential for extracellular vesicles (EVs) to be biomarkers of disease. A typical flow cytometer detects fluorescence and scatter intensities of single EVs in arbitrary units. These arbitrary units complicate data interpretation and data comparison between different flow cytometers. For example, comparison of detected EV concentrations requires knowledge of the detectable EV sizes. Using Mie theory and knowledge of the optical configuration of the flow cytometer, EV size can be derived from the scatter intensity for a given EV refractive index. Here, a protocol is described to derive the size of EVs and other nanoparticles from the scatter intensity. The resulting size distribution allows the comparison of data between flow cytometers, which is a prerequisite for clinical application of EVs as biomarkers and may advance other fields where sizing of nanoparticles is essential. © 2018 by John Wiley & Sons, Inc.

流式细胞术通常用于研究细胞外囊泡(ev)作为疾病生物标志物的潜力。典型的流式细胞仪可以检测任意单位的单个ev的荧光和散射强度。这些任意单位使不同流式细胞仪之间的数据解释和数据比较复杂化。例如,比较检测到的EV浓度需要了解可检测到的EV大小。利用Mie理论和流式细胞仪光学结构的知识,可以从给定EV折射率的散射强度推导出EV尺寸。本文描述了一种从散射强度推导ev和其他纳米粒子尺寸的方法。由此产生的尺寸分布允许流式细胞仪之间的数据比较,这是ev作为生物标志物临床应用的先决条件,并可能推进纳米颗粒尺寸至关重要的其他领域。©2018 by John Wiley &儿子,Inc。
{"title":"Deriving Extracellular Vesicle Size From Scatter Intensities Measured by Flow Cytometry","authors":"Leonie de Rond,&nbsp;Frank A. W. Coumans,&nbsp;Rienk Nieuwland,&nbsp;Ton G. van Leeuwen,&nbsp;Edwin van der Pol","doi":"10.1002/cpcy.43","DOIUrl":"10.1002/cpcy.43","url":null,"abstract":"<p>Flow cytometry is commonly used to investigate the potential for extracellular vesicles (EVs) to be biomarkers of disease. A typical flow cytometer detects fluorescence and scatter intensities of single EVs in arbitrary units. These arbitrary units complicate data interpretation and data comparison between different flow cytometers. For example, comparison of detected EV concentrations requires knowledge of the detectable EV sizes. Using Mie theory and knowledge of the optical configuration of the flow cytometer, EV size can be derived from the scatter intensity for a given EV refractive index. Here, a protocol is described to derive the size of EVs and other nanoparticles from the scatter intensity. The resulting size distribution allows the comparison of data between flow cytometers, which is a prerequisite for clinical application of EVs as biomarkers and may advance other fields where sizing of nanoparticles is essential. © 2018 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"86 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.43","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36450591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 41
Clearing for Deep Tissue Imaging 深层组织成像清理
Q1 Health Professions Pub Date : 2018-07-13 DOI: 10.1002/cpcy.38
Michael Muntifering, Daniel Castranova, Gregory A. Gibson, Evan Meyer, Matthew Kofron, Alan M. Watson

Biologic tissues are generally opaque due to optical properties that result in scattering and absorption of light. Preparation of tissues for optical microscopy often involves sectioning to a thickness of 50-100 µm, the practical limits of light penetration and recovery. A researcher who wishes to image a whole tissue must acquire potentially hundreds of individual sections before rendering them into a three-dimensional volume. Clearing removes strongly light-scattering and light-absorbing components of a tissue and equalizes the refractive index of the imaging medium to that of the tissue. After clearing, the maximum depth of imaging is often defined by the microscope optics rather than the tissue. Such visibility enables the interrogation of whole tissues and even animals without the need to section. Researchers can study a biological process in the context of its three-dimensional environment, identify rare events in large volumes of tissues, and trace cells and cell-cell interactions over large distances. This article describes four popular clearing protocols that are relevant to a wide variety of scenarios across biologic disciplines: CUBIC, CLARITY, 3DISCO, and SeeDB. © 2018 by John Wiley & Sons, Inc.

生物组织通常是不透明的,因为光学特性会导致光的散射和吸收。用于光学显微镜的组织制备通常需要切片至50-100 μ m的厚度,这是光穿透和恢复的实际极限。想要对整个组织成像的研究人员,在将其绘制成三维体积之前,必须获得数百个单独的切片。清除去除组织的强光散射和光吸收成分,并使成像介质的折射率与组织的折射率相等。清除后,成像的最大深度通常由显微镜光学而不是组织来确定。这种可见性使整个组织甚至动物的审讯不需要切片。研究人员可以在三维环境中研究生物过程,识别大量组织中的罕见事件,并在远距离上追踪细胞和细胞间的相互作用。本文描述了四种流行的清除协议,它们与生物学学科的各种场景相关:CUBIC、CLARITY、3DISCO和SeeDB。©2018 by John Wiley &儿子,Inc。
{"title":"Clearing for Deep Tissue Imaging","authors":"Michael Muntifering,&nbsp;Daniel Castranova,&nbsp;Gregory A. Gibson,&nbsp;Evan Meyer,&nbsp;Matthew Kofron,&nbsp;Alan M. Watson","doi":"10.1002/cpcy.38","DOIUrl":"10.1002/cpcy.38","url":null,"abstract":"<p>Biologic tissues are generally opaque due to optical properties that result in scattering and absorption of light. Preparation of tissues for optical microscopy often involves sectioning to a thickness of 50-100 µm, the practical limits of light penetration and recovery. A researcher who wishes to image a whole tissue must acquire potentially hundreds of individual sections before rendering them into a three-dimensional volume. Clearing removes strongly light-scattering and light-absorbing components of a tissue and equalizes the refractive index of the imaging medium to that of the tissue. After clearing, the maximum depth of imaging is often defined by the microscope optics rather than the tissue. Such visibility enables the interrogation of whole tissues and even animals without the need to section. Researchers can study a biological process in the context of its three-dimensional environment, identify rare events in large volumes of tissues, and trace cells and cell-cell interactions over large distances. This article describes four popular clearing protocols that are relevant to a wide variety of scenarios across biologic disciplines: CUBIC, CLARITY, 3DISCO, and SeeDB. © 2018 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"86 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.38","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36309713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Resolution of Viable and Membrane-Compromised Free Bacteria in Aquatic Environments by Flow Cytometry 用流式细胞术分离水生环境中活菌和膜受损的游离细菌
Q1 Health Professions Pub Date : 2018-06-29 DOI: 10.1002/cpcy.42
Gérald Grégori, Michel Denis, Sergio Sgorbati, Sandra Citterio

In aquatic environments, free heterotrophic bacteria play an extremely important role due to their high biomass, wide panel of metabolisms, and ubiquity, as well as the toxicity of certain species. This unit presents a nucleic-acid double-staining protocol (NADS) for flow cytometry that can distinguish fractions of viable, damaged, or membrane-compromised cells within the free-bacterial community. The NADS protocol is based on the simultaneous utilization of two nucleic acid stains—membrane-permeant SYBR Green and membrane-impermeant propidium iodide (PI). The efficiency of the double staining on fresh samples is magnified by the FRET from SYBR Green to PI when both are bound to the nucleic acids. Full quenching of SYBR Green fluorescence by PI identifies cells with a compromised membrane, partial quenching indicates cells with a slightly damaged membrane, and lack of quenching characterizes cells with an intact membrane. Samples do not require any pretreatment and this protocol can be performed almost anywhere. © 2018 by John Wiley & Sons, Inc.

在水生环境中,游离异养细菌由于其高生物量、广泛的代谢、无处不在以及某些物种的毒性而发挥着极其重要的作用。该装置提出了一种核酸双染色方案(NADS),用于流式细胞术,可以区分游离细菌群落中存活,受损或膜受损细胞的部分。NADS方案是基于同时利用两种核酸染色-膜渗透SYBR绿和膜不渗透碘化丙啶(PI)。当两者都与核酸结合时,双染色在新鲜样品上的效率被从SYBR Green到PI的FRET放大。PI对SYBR Green荧光的完全猝灭表明细胞膜受损,部分猝灭表明细胞膜轻微受损,而不猝灭表明细胞膜完好。样品不需要任何预处理,该方案几乎可以在任何地方执行。©2018 by John Wiley &儿子,Inc。
{"title":"Resolution of Viable and Membrane-Compromised Free Bacteria in Aquatic Environments by Flow Cytometry","authors":"Gérald Grégori,&nbsp;Michel Denis,&nbsp;Sergio Sgorbati,&nbsp;Sandra Citterio","doi":"10.1002/cpcy.42","DOIUrl":"10.1002/cpcy.42","url":null,"abstract":"<p>In aquatic environments, free heterotrophic bacteria play an extremely important role due to their high biomass, wide panel of metabolisms, and ubiquity, as well as the toxicity of certain species. This unit presents a nucleic-acid double-staining protocol (NADS) for flow cytometry that can distinguish fractions of viable, damaged, or membrane-compromised cells within the free-bacterial community. The NADS protocol is based on the simultaneous utilization of two nucleic acid stains—membrane-permeant SYBR Green and membrane-impermeant propidium iodide (PI). The efficiency of the double staining on fresh samples is magnified by the FRET from SYBR Green to PI when both are bound to the nucleic acids. Full quenching of SYBR Green fluorescence by PI identifies cells with a compromised membrane, partial quenching indicates cells with a slightly damaged membrane, and lack of quenching characterizes cells with an intact membrane. Samples do not require any pretreatment and this protocol can be performed almost anywhere. © 2018 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"85 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.42","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36270589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Mitochondrial Subtype Identification and Characterization 线粒体亚型鉴定与表征
Q1 Health Professions Pub Date : 2018-06-26 DOI: 10.1002/cpcy.41
Joseph R. Daniele, Kartoosh Heydari, Andrew Dillin

Healthy, functional mitochondria are central to many cellular and physiological phenomena, including aging, metabolism, and stress resistance. A key feature of healthy mitochondria is a high membrane potential (Δψ) or charge differential (i.e., proton gradient) between the matrix and inner mitochondrial membrane. Mitochondrial Δψ has been extensively characterized via flow cytometry of intact cells, which measures the average membrane potential within a cell. However, the characteristics of individual mitochondria differ dramatically even within a single cell, and thus interrogation of mitochondrial features at the organelle level is necessary to better understand and accurately measure heterogeneity. Here we describe a new flow cytometric methodology that enables the quantification and classification of mitochondrial subtypes (via their Δψ, size, and substructure) using the small animal model C. elegans. Future application of this methodology should allow research to discern the bioenergetic and mitochondrial component in a number of human disease and aging models, including, C. elegans, cultured cells, small animal models, and human biopsy samples. © 2018 by John Wiley & Sons, Inc.

健康、功能性的线粒体是许多细胞和生理现象的核心,包括衰老、新陈代谢和抗逆性。健康线粒体的一个关键特征是高膜电位(Δψ)或基质和线粒体内膜之间的电荷差(即质子梯度)。线粒体Δψ已经通过完整细胞的流式细胞术广泛表征,测量细胞内的平均膜电位。然而,即使在单个细胞内,单个线粒体的特征也存在显著差异,因此在细胞器水平上对线粒体特征的研究对于更好地理解和准确测量异质性是必要的。在这里,我们描述了一种新的流式细胞术方法,可以使用小动物模型秀丽隐杆线虫对线粒体亚型(通过它们的Δψ、大小和亚结构)进行量化和分类。该方法的未来应用将使研究能够在许多人类疾病和衰老模型中识别生物能量和线粒体成分,包括秀丽隐杆线虫、培养细胞、小动物模型和人类活检样本。©2018 by John Wiley &儿子,Inc。
{"title":"Mitochondrial Subtype Identification and Characterization","authors":"Joseph R. Daniele,&nbsp;Kartoosh Heydari,&nbsp;Andrew Dillin","doi":"10.1002/cpcy.41","DOIUrl":"10.1002/cpcy.41","url":null,"abstract":"<p>Healthy, functional mitochondria are central to many cellular and physiological phenomena, including aging, metabolism, and stress resistance. A key feature of healthy mitochondria is a high membrane potential (Δψ) or charge differential (i.e., proton gradient) between the matrix and inner mitochondrial membrane. Mitochondrial Δψ has been extensively characterized via flow cytometry of intact cells, which measures the average membrane potential within a cell. However, the characteristics of individual mitochondria differ dramatically even within a single cell, and thus interrogation of mitochondrial features at the organelle level is necessary to better understand and accurately measure heterogeneity. Here we describe a new flow cytometric methodology that enables the quantification and classification of mitochondrial subtypes (via their Δψ, size, and substructure) using the small animal model <i>C. elegans</i>. Future application of this methodology should allow research to discern the bioenergetic and mitochondrial component in a number of human disease and aging models, including, <i>C. elegans</i>, cultured cells, small animal models, and human biopsy samples. © 2018 by John Wiley &amp; Sons, Inc.</p>","PeriodicalId":11020,"journal":{"name":"Current Protocols in Cytometry","volume":"85 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/cpcy.41","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36259061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Current Protocols in Cytometry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1